Combining Value, Growth and Momentum
10x Stocks - Searching for multibaggers
  • Blog
  • Performance
  • Investment strategy
  • About

Arvind Remedies Ltd - Potential multibagger

9/6/2014

7 Comments

 
Arvind Remedies Ltd was established in 1988 under Dr.Arvind Shah, Managing Director and CEO. The company has 30 pharmaceutical brands in 10 states. They offer various products in GP segments like Analgesics, Antioxidants, Haematinics, Antibiotic, GIT drugs, and also specialty herbal products for diabetes and herbal cream for bed sores and prevention of keloids after surgery or wounds. The stock has a market cap of 397 Rs.Cr.

The world pharma market is estimated to have grown by 2.5% in 2013 to reach the size of US $ 975 bn. While average revenue growth in  developed markets was only .36% in emerging markets of Asia Africa Australia and Latin America, the growth was about 10.7%. 
United States remains the largest pharmaceutical market globally, and also the largest generics market.

The Indian pharma industry during 2013-14 grew by mere 6.1% and reached size of approx Rs.823 bn. 
However it has been globally ranked third in terms of volume and tenth in terms of value. The market is 
expected to grow at a compounded Annual Growth Rate of 12% over the next five years. 

The key factors influence growth of healthcare sector are growth in population, increasing incidence of 
diseases, increasing affordability, rise in insurance and government schemes. 

According to their annual report, this will be the company's main focus and growth strategy:

"ARL can play vital role by going for registration of off patented products for exports and developing the outsourcing market. Key strategy will be to focus on the new and latest molecules approved by the authorities and share with top companies who can market these products, focus on additional dosages in large and small volume parenterals and injectables in powder and liquid forms."


Let's take a look at ARL financials:
Picture
Arvind's revenues and profits have skyrocketed over the past couple of years, with margins improving significantly even in the face of competition. That is a great sign, the Indian pharma market has grown steadily, but attracted a lot of competition. If Arvind Remedies can expand margins in such an environment. Long-term debt/equity is slightly above 1, which is higher than the industry average, however they have enough current assets to satisfy near term  obligations.

There are two major red flags with Arvind Remedies: inventories rising faster than sales (58% vs. 38%), and operating cash flow was negative last year, due to an increase in receivables and inventories. Rising inventories might mean, that ARL is preparing for a good season or that demand is low and the company keeps producing goods that nobody is buying. In this case, I think I will stick to the first option, as they managed this really well in the past.

Valuation

Using a 3 stage DCF model I came up with the following value:
- 16%,18%,20% discount rates
- Long term growth of 20% for the next 5 years, 10% for years 6-10
- 4% terminal growth rate
Picture
Arvind Remedies valuation
The company looks dirt cheap. Using conservative estimates (20% growth and a 20% discount rate), I arrived at a value of 756 Rs.Cr., which implies a share value of 110 Rs. That's a potential of at least 90% in that stock, and if it grows faster (last year sales and profits grew 40%), it can be a multibagger. With a P/E of 5.8 and P/S of 0.4, the stock looks like a total bargain.

Summary

The stock has been on the run after the company cancelled a planned demerger of it's new factory, which will produce generics for the US market. Arvind Remedies offers a great risk/reward scenario - if it doesn't work out, my stop loss will be hit and I will lose a small amount, however if it continues to grow like in the past, it is significantly undervalued. The stock needs to cross the 60 Rs. mark before I buy it.
Picture
7 Comments
Sarath
9/7/2014 02:39:40 am

Thanks for analysis on Arvind remedies, Can you please share what should be the stop loss to be set if one decides to invest on this stock.

Reply
Best Stocks Right Now
9/7/2014 01:37:22 pm

Hello, I will use a 20% stop in this case, which is my maximum limit. But I will buy the stock only if it crosses the 60 Rs. mark to a new high. Given that I set a larger stop loss here, I am going with a smaller position, that means no more than 7.5% of my portfolio in this particular stock.

Reply
Sarath
9/8/2014 12:27:02 am

Thank you very much for your prompt reply, I took a small position yesterday just below 60.

Funny thing is that I have bough this stock when it is around 2 rs in 2009 and sold it for very minimal profit, now I am buying at 60.

Hopefully it works out good this time.

Appreciate your efforts on this site, it is really useful, I missed out on Insecticides thinking that I will buy it in correction at lower price which never happened. My bad.

Reply
Best Stocks Right Now
9/9/2014 02:29:44 pm

Wow, too bad you sold it, buying at 2 Rs. was really good. I believe it will work out now, as the stock still has a lot of potential, time will show us. Insecticides went up really fast, but that's always the case with strongest stocks, a correction might not happen for several months.

Reply
Sarath
9/10/2014 03:45:38 am

Thank you!

Reply
arnab
9/15/2014 11:57:40 pm

Dear, Today Arvind dips 20%. cmp Rs. 50.85. I took a small position @ Rs. 61.35. Whats your view? Thanks in advance.

Reply
Best Stocks Right Now
9/16/2014 01:13:32 am

Hello,

yes, today was really bad. It hit my 20% rule so I sold the stock. I had around 5% of my portfolio in it, the total loss is around 1%. This one really didn't work out. Good luck in the future.

Reply



Leave a Reply.

    To make money in stocks you must have the "the vision to see them, the courage to buy them and the patience to hold them". And patience is the rarest of the three.  Thomas Phelps

    Follow @BestStocksNow

    Categories

    All
    Best Stocks Of 2013
    Best Stocks Of 2014
    HK Stocks
    Indian Stocks
    Long
    Uk Stocks
    US Stocks

    Archives

    April 2021
    January 2021
    September 2020
    August 2020
    May 2020
    August 2019
    July 2019
    June 2019
    February 2019
    May 2018
    August 2017
    July 2016
    February 2016
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    September 2014
    August 2014
    July 2014
    June 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013

    RSS Feed

Powered by Create your own unique website with customizable templates.